Clinical Trials: Understanding and Perceptions of Female Chinese-American Cancer Patients

por Tu, Shin-Ping, Chen, Hueifang, Chen, Anthony, Lim, Jeanette, May, Suepattra, Drescher, Charles
Publicado 2005

Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling

por Pocobelli, Gaia, Chubak, Jessica, Hanson, Nancy, Drescher, Charles, Resta, Robert, Urban, Nicole, Buist, Diana S.M.
Publicado 2012

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125

por Schummer, Michèl, Drescher, Charles, Forrest, Robin, Gough, Shirley, Thorpe, Jason, Hellström, Ingegerd, Hellström, Karl Erik, Urban, Nicole
Publicado 2011

Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening

por Drescher, Charles W., Hawley, Sarah, Thorpe, Jason D., Marticke, Simone, McIntosh, Martin, Gambhir, Sanjiv, Urban, Nicole
Publicado 2012

Dangerous Combinations: Ingestible CAM Supplement Use During Chemotherapy in Patients with Ovarian Cancer

por Andersen, M. Robyn, Sweet, Erin, Lowe, Kimberly A., Standish, Leanna J., Drescher, Charles W., Goff, Barbara A.
Publicado 2013

Involvement in decision-making about treatment and ovarian cancer survivor quality of life

por Andersen, M. Robyn, Sweet, Erin, Lowe, Kimberly A., Standish, Leanna J., Drescher, Charles W., Goff, Barbara A.
Publicado en Gynecol Oncol (2011)

Extracting a low-dimensional description of multiple gene expression datasets reveals a potential driver for tumor-associated stroma in ovarian cancer

por Celik, Safiye, Logsdon, Benjamin A., Battle, Stephanie, Drescher, Charles W., Rendi, Mara, Hawkins, R. David, Lee, Su-In
Publicado en Genome Med (2016)

Prophylactic in vivo hematopoietic stem cell gene therapy with an immune checkpoint inhibitor reverses tumor growth in syngeneic mouse tumor models

por Li, Chang, Course, Meredith M., McNeish, Iain A., Drescher, Charles W., Valdmanis, Paul N., Lieber, André
Publicado en Cancer Res (2019)

Ultrasound Molecular Imaging in a Human CD276 Expression-Modulated Murine Ovarian Cancer Model

por Lutz, Amelie M., Bachawal, Sunitha V., Drescher, Charles W., Pysz, Marybeth A., Willmann, Jürgen K., Gambhir, Sanjiv Sam
Publicado 2014

Desmoglein-2 as a prognostic and biomarker in ovarian cancer

por Kim, Jiho, Beidler, Peter, Wang, Hongjie, Li, Chang, Quassab, Abdullah, Coles, Cari, Drescher, Charles, Carter, Darrick, Lieber, André
Publicado en Cancer Biol Ther (2020)

Digital Quantification of Tumor Infiltrating Lymphocytes

por Robins, Harlan S., Ericson, Nolan G., Guenthoer, Jamie, O'Briant, Kathy C., Tewari, Muneesh, W.Drescher, Charles, Bielas, Jason H.
Publicado 2013

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors

por Buas, Matthew F., Gu, Haiwei, Djukovic, Danijel, Zhu, Jiangjiang, Drescher, Charles W., Urban, Nicole, Raftery, Daniel, Li, Christopher I.
Publicado en Gynecol Oncol (2015)

BIOMARKERS AND STRATEGIES FOR EARLY DETECTION OF OVARIAN CANCER

por Bast, Robert C., Lu, Zhen, Han, Chae Young, Lu, Karen H., Anderson, Karen S., Drescher, Charles W., Skates, Steven J.
Publicado en Cancer Epidemiol Biomarkers Prev (2020)

Bead-based ELISA assays for validation of ovarian cancer early detection markers

por Scholler, Nathalie, Crawford, Meghan, Sato, Alicia, Drescher, Charles W., O’Briant, Kathy C., Kiviat, Nancy, Anderson, Garnet L., Urban, Nicole
Publicado 2006

Use of a Symptom Index, CA125 and HE4 to predict ovarian cancer

por Andersen, M. Robyn, Goff, Barbara A., Lowe, Kimberly A., Scholler, Nathalie, Bergan, Lindsay, Drescher, Charles W., Paley, Pamela, Urban, Nicole
Publicado 2009

False-positive screening events and worry influence decisions about surgery among high-risk women

por Andersen, M. Robyn, Karlan, Beth Y., Drescher, Charles W., Paley, Pam, Hawley, Sarah, Palomares, Melanie, Daly, Mary, B., Urban, Nicole
Publicado en Health Psychol (2018)

Targeted single molecule mutation detection with massively parallel sequencing

por Gregory, Mark T., Bertout, Jessica A., Ericson, Nolan G., Taylor, Sean D., Mukherjee, Rithun, Robins, Harlan S., Drescher, Charles W., Bielas, Jason H.
Publicado en Nucleic Acids Res (2016)

Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells

por Saydaminova, Kamola, Strauss, Robert, Xie, Min, Bartek, Jiri, Richter, Maximilian, van Rensburg, Ruan, Drescher, Charles, Ehrhardt, Anja, Ding, Sheng, Lieber, André
Publicado en Cancer Biol Ther (2016)

Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells()()

por Cai, Xin, Caballero-Benitez, Andrea, Gewe, Mesfin M., Jenkins, Isaac C., Drescher, Charles W., Strong, Roland K., Spies, Thomas, Groh, Veronika
Publicado en Neoplasia (2017)

ESRRA-C11orf20 Is a Recurrent Gene Fusion in Serous Ovarian Carcinoma

por Salzman, Julia, Marinelli, Robert J., Wang, Peter L., Green, Ann E., Nielsen, Julie S., Nelson, Brad H., Drescher, Charles W., Brown, Patrick O.
Publicado 2011